NFKB1 and cancer: Although the mechanisms controlling the incorporation of Ni2+ ions are unknown, the fact that Ni2+ ions can inhibit NF-κB activity by binding directly to p50 suggests possible clinical applications for Ni2+ ions in cancer therapy.